Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Diversity, Equity, & Inclusion (DEI)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit New Manuscript
    • Submit Revised Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

August 28, 2012; 79 (9) Resident and Fellow Section

Teaching NeuroImages: Isolated hypothalamic hamartoma vs Pallister-Hall syndrome

Imaging and clinical correlation

Antonio J. da Rocha, Marcos Rosa Junior, Fernando Norio Arita
First published August 27, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182676796
Antonio J. da Rocha
From the Divisions of Neuroradiology (A.J.d.R., M.R.J.) and Pediatric Neurology (F.N.A.), Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcos Rosa Junior
From the Divisions of Neuroradiology (A.J.d.R., M.R.J.) and Pediatric Neurology (F.N.A.), Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Norio Arita
From the Divisions of Neuroradiology (A.J.d.R., M.R.J.) and Pediatric Neurology (F.N.A.), Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Teaching NeuroImages: Isolated hypothalamic hamartoma vs Pallister-Hall syndrome
Imaging and clinical correlation
Antonio J. da Rocha, Marcos Rosa Junior, Fernando Norio Arita
Neurology Aug 2012, 79 (9) 950-951; DOI: 10.1212/WNL.0b013e3182676796

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
867

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Isolated hypothalamic hamartomas (HH) have a distinct clinical phenotype from that of Pallister-Hall syndrome (PHS), as HH consist of more severe seizures and cognitive, behavioral, and endocrine disorders.1 The imaging features help one to distinguish these conditions (figures 1 and 2).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1 Isolated hypothalamic hamartoma (HH) (3-year-old boy) with gelastic epilepsy and precocious puberty

(A, B) MRI confirmed nonenhancing HH (arrows). Typical hyperintensity on fluid-attenuated inversion recovery (arrowhead). (C) Advanced bone age.

Figure 2
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2 Pallister-Hall syndrome (2-year-old boy)

(A, B) MRI confirmed nonenhancing hypothalamic hamartoma (arrow) that was isointense to gray matter on fluid-attenuated inversion recovery (arrowhead). (C, D) Note the curved long bones, polydactyly, and dysplastic metatarsal (asterisks).

Isolated HH are hyperintense on fluid-attenuated inversion recovery and cause precocious puberty (PP) when they are oriented downward (parahypothalamic lesion), while seizures predominate in sessile intrahypothalamic HH.2 PHS is associated with isointense to gray matter HH, polydactyly, cutaneous syndactyly, bifid epiglottis, imperforate anus, and panhypopituitarism, resulting from GLI3 frameshift mutations (which map to chromosome 7p13) as an autosomal dominant trait.1

AUTHOR CONTRIBUTIONS

Dr. Rocha was responsible for the study concept, writing the manuscript, and the interpretation of data. Dr. Rosa Jr. was responsible for the interpretation of data and image selection. Dr. Arita was responsible for the clinical study concept and critical revision of the manuscript.

Mystery Case responses

The Mystery Case series was initiated by the Neurology® Resident & Fellow Section to develop the clinical reasoning skills of trainees. Residency programs, medical student preceptors, and individuals were invited to use this Mystery Case as an education tool. Responses were solicited through a group e-mail sent to the AAN Consortium of Neurology Residents and Fellows and through social media.

All the answers that we received came from individual residents rather than groups and they were all well-reasoned and thoughtful. Three respondents correctly identified the classic appearance of isolated hypothalamic hamartomas (figure 1) and Pallister-Hall syndrome (figure 2). When isolated, hypothalamic hamartomas present with severe epilepsy, more significant neurologic dysfunction, and are more likely to be associated with precocious puberty. Patients with Pallister-Hall syndrome usually have well-controlled seizures and endocrine disturbances other than precocious puberty.

The teaching point of this Mystery Case is that despite similar appearance the exact MRI localization and the T2/fluid-attenuated inversion recovery characteristics may help in differentiating between these 2 entities, and thus the imaging could be used as a prognostic factor for the clinical evolution.

Dragos A. Nita, MD, PhD

  • Copyright © 2012 by AAN Enterprises, Inc.

REFERENCES

  1. 1.↵
    1. Jung H,
    2. Neumaier Probst E,
    3. Hauffa BP,
    4. Partsch CJ,
    5. Dammann O
    . Association of morphological characteristics with precocious puberty and/or gelastic seizures in hypothalamic hamartoma. J Clin Endocrinol Metab 2003;88:4590–4595.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Boudreau EA,
    2. Liow K,
    3. Frattali CM,
    4. et al
    . Hypothalamic hamartomas and seizures: distinct natural history of isolated and Pallister-Hall syndrome cases. Epilepsia 2005;46:42–7.
    OpenUrlPubMed
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • AUTHOR CONTRIBUTIONS
    • Mystery Case responses
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy

Dr. Jeffrey Allen and Dr. Nicholas Purcell

► Watch

Related Articles

  • Spotlight on the November 20 Issue

Alert Me

  • Alert me when eletters are published

Recommended articles

  • Article
    Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma
    Atsushi Fujita, Takefumi Higashijima, Hiroshi Shirozu et al.
    Neurology, June 13, 2019
  • Articles
    Endoscopic resection of hypothalamic hamartomas for refractory symptomatic epilepsy
    Y. -T. Ng, H. L. Rekate, E. C. Prenger et al.
    Neurology, April 21, 2008
  • Articles
    Hypothalamic hamartomas and gelastic epilepsy
    A spectroscopic study
    E. Tasch, F. Cendes, L. M. Li et al.
    Neurology, October 01, 1998
  • Editorials
    Hypothalamic hamartomas and hedgehogs
    Not a laughing matter
    Samuel J. Pleasure, Renzo Guerrini et al.
    Neurology, February 19, 2008
Neurology: 100 (13)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise